Search Results - "Hoedemaeker, R F"

Guidelines for processing and reporting of prostatic needle biopsies by van der Kwast, Th H, Lopes, C, Santonja, C, Pihl, C-G, Neetens, I, Martikainen, P, Di Lollo, S, Bubendorf, L, Hoedemaeker, R F

“…The reported detection rate of prostate cancer, lesions suspicious for cancer, and prostatic intraepithelial neoplasia (PIN) in needle biopsies is highly…”
Get full text

Pathologic Features of Prostate Cancer Found at Population-Based Screening With a Four-Year Interval by Hoedemaeker, Robert F., van der Kwast, Theodorus H., Boer, Rob, de Koning, Harry J., Roobol, Monique, Vis, André N., Schröder, Fritz H.

“…Background: The currently recommended frequency for prostate-specific antigen (PSA) screening tests for prostate cancer is 1 year, but the optimal screening…”
Get full text

Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer by Rietbergen, J B, Kruger, A E, Hoedemaeker, R F, Bangma, C H, Kirkels, W J, Schröder, F H

“…We describe the yield of a repeat examination and biopsy procedure 1 year after initial biopsy was negative. We also assessed the parameters responsible for…”
Get more information

Histopathological prostate cancer characteristics at radical prostatectomy after population based screening by Hoedemaeker, R F, Rietbergen, J B, Kranse, R, Schröder, F H, van der Kwast, T H

“…Although early detection of prostate cancer by prostate specific antigen based screening results in a shift towards more clinically organ confined tumors,…”
Get more information

Human prostate-specific transglutaminase: a new prostatic marker with a unique distribution pattern by Dubbink, H J, Hoedemaeker, R F, van der Kwast, T H, Schröder, F H, Romijn, J C

“…Human prostate-specific transglutaminase (hTGp) is a cross-linking enzyme, the physiologic function of which has not been established unequivocally yet. To…”
Get more information

Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study by Rietbergen, John B.W, Kranse, Ries, Hoedemaeker, Robert F, Kruger, Arto E.Boeken, Bangma, Chris H, Kirkels, Wim J, Schröder, Fritz H

“…Objectives. To compare the discriminatory potential between prostate cancer and benign conditions of the prostate in a population-based screening study, of…”
Get full text

Evaluation of prostate needle biopsies in a population-based screening study : The impact of borderline lesions by HOEDEMAEKER, R. F, KRANSE, R, RIETBERGEN, J. B. W, KRUGER, A. E. B, SCHRÖDER, F. H, VAN DER KWAST, T. H

“…The finding of isolated high grade prostatic intraepithelial neoplasia (PIN) or borderline lesions (lesions suspicious for malignancy) in prostate needle…”
Get full text

Prostate cancer detection at low prostate specific antigen by Schröder, F H, van der Cruijsen-Koeter, I, de Koning, H J, Vis, A N, Hoedemaeker, R F, Kranse, R

“…At low prostate specific antigen (PSA) the indication for prostate biopsy is usually an abnormal digital rectal examination. We evaluate the diagnostic value…”
Get more information

Current topics in prostate cancer research by Hoedemaeker, R.F.

Get full text

Detection of prostate cancer : A comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy by VIS, André N, BOERMA, Michiel O, CIATTO, Stefano, HOEDEMAEKER, Robert F, SCHRÖDER, Fritz H, VAN DER KWAST, Theo H

“…The optimal biopsy strategy for the detection of prostate cancer still needs to be established, since a considerable proportion of clinically significant…”
Get full text

Molecular Cytogenetic Analysis of Prostatic Adenocarcinomas from Screening Studies : Early Cancers May Contain Aggressive Genetic Features by Alers, Janneke C, Krijtenburg, Pieter-Jaap, Vis, Andre N, Hoedemaeker, Robert F, Wildhagen, Mark F, Hop, Wim C. J, van der Kwast, Theodorus H, Schroder, Fritz H, Tanke, Hans J, van Dekken, Herman

“…No objective parameters have been found so far that can predict the biological behavior of early stages of prostatic cancer, which are encountered frequently…”
Get full text

The clinical significance of a small focus of well‐differentiated carcinoma at prostate biopsy by Hoedemaeker, R.F., Van Der Kwast, T.H., Schröder, F.H.

“…OBJECTIVE To compare a series of 121 sextant needle biopsy sets with their corresponding radical prostatectomy specimens in screened participants in the…”
Get full text

Features of prostate cancers detected during a prevalence screening round. The Rotterdam experience by Van der Kwast, Th H, Postma, R, Hoedemaeker, R F, van Leenders, G J L H, Schröder, F H

“…Prostate-specific antigen (PSA) testing of asymptomatic men may lead to the detection of "minimal" prostate cancers that are less likely to be associated with…”
Get more information

Staging prostate cancer by Hoedemaeker, Robert F., Vis, André N., Van Der Kwast, Theodorus H.

“…Determining tumor stage provides a systematic way to describe the amount and the extent of a tumor at a certain point in time. In this short overview, the…”
Get full text

Report of the Pathology Committee: false‐positive and false‐negative diagnoses of prostate cancer by Van Der Kwast, T.H., Lopes, C., Martikainen, P.M., Pihl, C.‐G., Santonja, C., Neetens, I., Di Lollo, S., Hoedemaeker, R.F.

Get full text

Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml) by Vis, André N., Hoedemaeker, Robert F., Roobol, Monique, van der Kwast, Theo H., Schröder, Fritz H.

“…BACKGROUND The value of rectal examination as initial screening test for prostate cancer at low PSA values (0.0–3.9 ng/ml) was determined by evaluating the…”
Get full text

The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancer by VIS, Andre N, HOEDEMAEKER, Robert F, ROOBOL, Monique, SCHRÖDER, Fritz H, VAN DER KWAST, Theo H

“…Suspicion of prostate carcinoma may persist after an initial negative biopsy result, and repeated biopsy is suggested. The authors assessed whether diagnostic…”
Get full text

Consistency of prostate cancer grading results in screened populations across Europe by Van der Kwast, T.H., Roobol, M.J., Wildhagen, M.F., Martikainen, P.M., Määtänen, L., Pihl, C.‐G., Santonja, C., Bubendorf, L., Neetens, I., Di Lollo, S., Hoedemaeker, R.F.

“…OBJECTIVE To assess the consistency of grading outcome among seven of eight participating centres of the European Randomised Screening Program of Prostate…”
Get full text

Rapid microwave-stimulated fixation of entire prostatectomy specimens by Ruijter, Emiel Th, Miller, Gary J., Aalders, Tilly W., Van De Kaa, Christina A., Schalken, Jack A., Debruyne, Frans M., Boon, Mathilde E.

“…Conventional fixation of large solid surgical specimens is a slow process. Consequently, autolytic damage to tissues may occur if the fixative does not reach…”
Get full text

Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer by Hoedemaeker, R F, Rietbergen, J B, Kranse, R, van der Kwast, T H, Schröder, F H

“…In recent years the introduction of serum prostate-specific antigen (PSA) determination as a screening tool for early detection of prostate cancer in…”
Get full text